Boston Scientific Announces Results For Third Quarter 2021

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a...

Related Keywords

Japan ,Malaysia ,Taiwan ,Philippines ,United States ,Brazil ,China ,Vietnam ,Republic Of ,Boston ,Massachusetts ,Czech Republic ,South Africa ,Colombia ,Indonesia ,Canada ,Russia ,Mexico ,India ,Thailand ,Saudi Arabia ,Chile ,South Korea ,Poland ,Turkey ,America ,Japanese ,Lauren Tengler ,Mike Mahoney ,Kate Haranis ,Boston Scientific Corporation ,Baylis Medical Company Inc ,Us Centers For Medicare ,A New Technology Payment ,Japanese Pharmaceuticals ,Medicaid Services ,Heart Rhythm Society Annual Meeting ,Boston Scientific ,Preventice Solutions Inc ,Pelvic Health ,Specialty Pharmaceuticals ,Exchange Commission ,Prnewswire Boston Scientific Corporation ,Us Food Drug Administration ,Devoro Medical Inc ,Securities Exchange ,Farapulse Inc ,Devices Agency ,European Society For Medical Oncology ,Scientific Corporation ,Middle East ,Medical Company ,Medical Inc ,Drug Administration ,Modelb Single Use Bronchoscope ,New Technology Add On Payment ,Modeld Single Use Duodenoscope ,Endovascular System ,Drug Eluting Vascular Stent System ,Drug Coated Balloon ,European Society ,Medical Oncology ,Clinical Oncology ,Heart Rhythm ,Heart Rhythm Society ,Annual Meeting ,Left Atrial Appendage Closure Devices ,Medical Devices Agency ,Cryoablation System ,Emerging Markets ,Medical Surgical ,Medical Devices ,Medical Device ,Full Year ,Fourth Quarter ,Preventice Solutions ,Statement Regarding Forward Looking Statements ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Quarterly Reports ,Months Ended September ,Mandatory Convertible Preferred Stock ,Before Income ,Financial Accounting Standards Board ,Accounting Standards Codification ,Estimated Annual Effective Tax Rate ,Financial Condition ,Quarterly Report ,